ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

A Class of Shark-Derived Single-Domain Antibodies can Broadly Neutralize SARS-Related Coronaviruses and the Structural Basis of Neutralization and Omicron Escape

Feng, Bo; Chen, Zhilong; Sun, Jing; Xu, Tingting; Wang, Qian; Yi, Haisu; Niu, Xuefeng; Zhu, Jiabin; Fan, Mengzhu; Hou, Ruitian; Shao, Ying; Huang, Sihui; Li, Cuiyun; Hu, Peiyu; Zheng, Pingqian; He, Ping; Luo, Jia; Yan, Qihong; Xiong, Xiaoli; Liu, Jinsong*; Zhao, Jincun*; Chen, Ling*广州医学院; 中国科学院; 1
Small Methods2022-7DOI: 10.1002/smtd.202200387
11被引8阅读
引用收藏
分享

摘要

The identification of a novel class of shark-derived single domain antibodies, named vnarbodies that show picomolar affinities binding to the receptor binding domain (RBD) of Wuhan and Alpha, Beta, Kappa, Delta, Delta-plus, and Lambda variants, is reported. Vnarbody 20G6 and 17F6 have broad neutralizing activities against all these SARS-CoV-2 viruses as well as other sarbecoviruses, including Pangolin coronavirus and Bat coronavirus. Intranasal administration of 20G6 effectively protects mice from the challenges of SARS-CoV-2 Wuhan and Beta variants. 20G6 and 17F6 contain a unique "WXGY" motif in the complementary determining region 3 that binds to a hidden epitope on RBD, which is highly conserved in sarbecoviruses through a novel beta-sheet interaction. It is found that the S375F mutation on Omicron RBD disrupts the structure of beta-strand, thus impair the binding with 20G6. The study demonstrates that shark-derived vnarbodies offer a prophylactic and therapeutic option against most SARS-CoV-2 variants and provide insights into antibody evasion by the Omicron variant.

学科与关键词

关键词
neutralizationreceptor binding domain (RBD)SARS-CoV-2variants of concerns (VOCs)
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Small Methods
发表日期
2022-07
卷期
第 6 卷, 第 7 期
页码
2200387
DOI
10.1002/smtd.202200387
期刊等级
2区
成果收录
SCIE
资助标注
Chinese Academy of Sciences Pilot Strategic Science and Technology Projects [XDB29050701]; Guangzhou Science and Technology Program Key Projects [2021904020037]; State Key Lab of Respiratory Disease, Guangzhou Medical University [SKLRD-QN-201901]; Youth Innovation Promotion Association of CAS [2021357]; Guangzhou Institute of Respiratory Health Open Project (Funds provided by China Evergrande Group) [2020GIRHHMS08]; China Postdoctoral Science Foundation [2020T130023ZX]

作者

  • F

    Feng, Bo (第一作者)

    1 · guangzhou med univ

  • C

    Chen, Zhilong

    huaqiao univ

查看全部 22 位作者收起作者
  • S

    Sun, Jing

    1 · guangzhou med univ

  • X

    Xu, Tingting

    chinese acad sci · guangzhou inst biomed & hlth

  • W

    Wang, Qian

    1 · guangzhou med univ

  • Y

    Yi, Haisu

    1 · guangzhou med univ

  • N

    Niu, Xuefeng

    1 · guangzhou med univ

  • Z

    Zhu, Jiabin

    1 · guangzhou med univ

  • F

    Fan, Mengzhu

    huaqiao univ

  • H

    Hou, Ruitian

    chinese acad sci · guangzhou inst biomed & hlth

  • S

    Shao, Ying

    huaqiao univ

  • H

    Huang, Sihui

    huaqiao univ

  • L

    Li, Cuiyun

    chinese acad sci · guangzhou inst biomed & hlth

  • H

    Hu, Peiyu

  • Z

    Zheng, Pingqian

  • H

    He, Ping

    chinese acad sci · guangzhou inst biomed & hlth

  • L

    Luo, Jia

  • Y

    Yan, Qihong

    chinese acad sci · guangzhou inst biomed & hlth

  • X

    Xiong, Xiaoli

    chinese acad sci · guangzhou inst biomed & hlth

  • L

    Liu, Jinsong (通讯)

    chinese acad sci · guangzhou inst biomed & hlth

  • Z

    Zhao, Jincun (通讯)

    1 · guangzhou med univ

  • C

    Chen, Ling (通讯)

    huaqiao univ · 1 · guangzhou med univ · chinese acad sci · guangzhou inst biomed & hlth

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417